FibroGen, Inc (FGEN) by event type
FGEN moves most on coverage initiations — a median of +1.43% at 30 minutes across 38 measured events. Each row is measured over the last three years and read against the price at its own news timestamp. Back to the FGEN overview →
How FGEN reacts across 2 measured event types.
| Event | Events | Median 30-min | % positive | Median to close |
|---|---|---|---|---|
| Coverage initiations 87 of 2,283 | 38 | +1.43% | 63% | +0.54% |
| Rating reiterations 110 of 3,522 | 13 | +0.62% | 62% | -3.38% |
Last 3 years, pulled 2026-09-21. Reaction = percent move vs. the price at the news timestamp. Counts and medians only. The rank under each event type orders every name measured for it by median 30-min reaction, most positive first — so a low rank on a downgrade means this name falls harder than most, not that it moves less. Names with an identical median share a rank; a name the cross-section does not carry shows no rank rather than a guessed one. 3 further classes were observed with fewer than 10 measured events and are not published.
That’s how FGEN usually reacts — get an email when it moves on news →Every name measured for these event types: Coverage initiations → · Rating reiterations → · FGEN overview →
Other Healthcare names, measured the same way
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| OASMIA PHARMACEUTICALS AB AMERICAN DEPOSITARY SHARE (OASM) | 223 | 0.00% | 35% |
| Atossa Therapeutics, Inc. (ATOS) | 222 | -0.02% | 48% |
| INNOVATE BIOPHARMACEUTICALS (INNT) | 220 | -0.77% | 38% |
| OWC PHARMS RESEARCH CORP (OWCP) | 220 | +0.09% | 52% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not.